Journal profile · PRIMARY HEALTH CARE

Medicina de Familia-SEMERGEN

ISSN 1138-3593 · eISSN 1578-8865 · Elsevier

Medicina de Familia-SEMERGEN: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1 (journal website); hybrid open access; APC about USD 1,860; median 60 days to acceptance (110 articles, last 24 months); acceptance rate 44% (journal website); 133 articles in 2025; indexed in ESCI and Scopus.

Impact factor1From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time60 daysMedian, submission to acceptance · 110 articles, last 24 months · PubMed
APCUSD 1,860Hybrid journal: charged only for open-access articles
Acceptance44%From the journal's website
Articles per year1332025 · OpenAlex count

Scope

Aims, scope and focus

Medicina de Familia-SEMERGEN is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Healthcare Systems and Technology, Health and Medical Education and Health and Lifestyle Studies, together about 23.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Family Medicine (Medicina de Familia - SEMERGEN) is the official scientific publication of the Spanish Society of Primary Care Physicians (Sociedad Española de Médicos de Atención Primaria) and has as its main aim to promote research and professional skills of Primary Care Physicians in order to improve the health and care of the population. Medicina de Familia - SEMERGEN seeks to identify questions on high quality Primary Healthcare focused on the patient and/or the community. The journal publishes original research, methodologies, and theories, as well as selected systematic reviews that are based on current knowledge in order to put forward new theories, methods, or lines of research. Medicina de Familia - SEMERGEN is a peer-reviewed journal that has adopted clear and rigorous ethical norms in its publication policy following the rules of the Publications Ethics Committee, and which seeks to identify questions on high-quality Primary Healthcare focused on the patient and on the community. The journal accepts articles in Spanish and English. The journal is indexed in MedLine/PubMed and SCOPUSMedicina de Familia - SEMERGEN es el vehículo de comunicación de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) en su misión de promover la investigación y la competencia profesional de los médicos de atención primaria para mejorar la salud y la asistencia a la población. Medicina de Familia - SEMERGEN busca identificar preguntas sobre la atención primaria de salud y la provisión de atención de alta calidad centrada en el paciente y/o la comunidad. Publicamos investigaciones, metodologías y teorías originales, así como revisiones sistemáticas seleccionadas que se basan en el conocimiento actual para avanzar en nuevas teorías, métodos o líneas de investigación. Medicina de Familia - SEMERGEN es una revista de revisión por pares que ha adoptado pautas éticas claras y rigurosas en su política de publicaciones siguiendo las pautas del Comité de Ética de Publicaciones y que busca identificar y dar respuesta a preguntas sobre la atención primaria de salud y la provisión de atención de alta calidad centrada en el paciente y en la comunidad. La revista acepta articulos en Español y en Inglés. La revista está incluida en MedLine/PubMed y SCOPUS.

From the journal's Aims & Scope

Research area (LetPub): PRIMARY HEALTH CARE

Editor-in-chief Vicente MartínPublisher website

Editorial board by country: none in mainland China; most named Spain 44, United States 5, United Kingdom 4 (53 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Healthcare Systems and TechnologyBusiness, Management and Accounting8.6%
  2. Health and Medical EducationHealth Professions8.3%
  3. Health and Lifestyle StudiesHealth Professions6.8%
  4. Blood Pressure and Hypertension StudiesMedicine6.6%
  5. Aging, Health, and DisabilityMedicine5.6%
  6. Diabetes, Cardiovascular Risks, and LipoproteinsMedicine4.4%
  7. Venous Thromboembolism Diagnosis and ManagementMedicine4.2%
  8. Atrial Fibrillation Management and OutcomesMedicine4.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPrimary Health CareZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPrimary Health CareZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPubMedPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
1Publisher website ·
CiteScore 2026-06
1LetPub ·
CiteScore (publisher)
1Publisher website ·
SJR 2026-06
0.25LetPub ·
SNIP 2026-06
0.31LetPub ·
h-index
25OpenAlex ·
i10-index
192OpenAlex ·
2-year mean citedness
0.64OpenAlex ·
Self-citation rate
10%LetPub ·
Share of gold OA articles
7.01%LetPub ·

Volume

Articles per year
68LetPub ·

Articles by year OpenAlex count · 3,621 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261302815
20251331492
202415614163
202311721236
202210923330
202110729333

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

60 daysMedian, submission to acceptance · P25–P75 31 days – 100 days

Acceptance to online
median 39 days (110 articles)
Submission to online
median 100 days
Sample
110 articles with submission and acceptance dates (372 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Acceptance rate (publisher)
44%Publisher website ·
Submission to first decision
11 daysPublisher website ·
First decision after review
38 daysPublisher website ·
Submission to acceptance
64 daysPublisher website ·
Peer review
Double anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 1,860 / EUR 1,700 / GBP 1,490 / JPY 230,700——
Publisher websiteUSD 2,000——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted8, with length limits
  1. continuing educationUpdated review papers on different aspects detailed below will be published. Continuing education articles will be commissioned, however, articles submitted vol…Length not stated
  2. editorialAny article submitted to this journal must follow the guidelines outlined in the "Ethics and Policies" section of this author’s guide. It is essential to consul…main text ≤ 1,200 words · figures and tables ≤ 4
  3. letters to the editorAny article submitted to this journal must follow the guidelines outlined in the "Ethics and Policies" section of this author’s guide. It is essential to consul…main text ≤ 500 words
  4. opinionAny article submitted to this journal must follow the guidelines outlined in the "Ethics and Policies" section of this author’s guide. It is essential to consul…Length not stated
  5. original articleThese should be original research papers and other contributions about etiology, physiopathology, epidemiology, diagnoses and treatments. Manuscripts should be …main text ≤ 3,000 words · abstract ≤ 250 words · figures and tables ≤ 12 · references ≤ 30
  6. original research paperAny article submitted to this journal must follow the guidelines outlined in the "Ethics and Policies" section of this author’s guide. It is essential to consul…Length not stated
  7. reviewAny article submitted to this journal must follow the guidelines outlined in the "Ethics and Policies" section of this author’s guide. It is essential to consul…main text ≤ 5,000 words · abstract ≤ 150 words
  8. viewpointAny article submitted to this journal must follow the guidelines outlined in the "Ethics and Policies" section of this author’s guide. It is essential to consul…Length not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Open access, Peer review, Preprints
Authorship Authorship

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

Source ↗Publisher website ·
Conflicts of interest Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

Source ↗Publisher website ·
Open access Open Access

Article Publishing Charge (APC): USD 2,000 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.

Source ↗Publisher website ·
Peer review Peer review

Double anonymized review process; initial editor assessment; minimum of two independent expert reviewers; Editor responsible for final decision. Model summary

This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

Source ↗Publisher website ·
Preprints Preprint references

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Elsevier
ISSN
1138-3593
Electronic ISSN
1578-8865
Official links

FAQ

Frequently asked questions about Medicina de Familia-SEMERGEN

What CAS zone is Medicina de Familia-SEMERGEN in?

In the 2025 upgraded edition of the CAS Journal Ranking, Medicina de Familia-SEMERGEN is in Zone 4 of Medicine, and in Zone 4 of the minor category Primary Health Care. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Medicina de Familia-SEMERGEN?

The journal's website gives an impact factor of 1; this is the journal's own figure, as LetPub lists none for it; CiteScore 1, h-index 25.

How long does peer review take at Medicina de Familia-SEMERGEN?

Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 60 days (interquartile range 31–100 days); the journal's website gives an acceptance rate of 44%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Medicina de Familia-SEMERGEN based?

Of the 53 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (44), United States (5) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.

Which databases index Medicina de Familia-SEMERGEN?

According to LetPub and DOAJ records, Medicina de Familia-SEMERGEN is indexed in ESCI and Scopus. The journal's website also lists MEDLINE and PubMed; that list has not been checked against each database.

Is Medicina de Familia-SEMERGEN open access, and what is the APC?

Medicina de Familia-SEMERGEN is a hybrid journal. For open-access publication: APC about USD 1,860.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .